Camrelizumab, apatinib and hepatic artery infusion chemotherapy combined with microwave ablation for advanced hepatocellular carcinoma

Figure 5 Forest plot showing the factors associated with overall survival and progression-free survival in patients with advanced hepatocellular carcinoma who received camrelizumab plus apatinib and hepatic artery infusion chemotherapy alone and camrelizumab plus apatinib and hepatic artery infusion chemotherapy combined with microwave ablation. A: Overall survival in all patients; B: Progression-free survival in all patients. T-M: Camrelizumab plus apatinib and hepatic artery infusion chemotherapy combined with MWA; T-A: Camrelizumab plus apatinib and hepatic artery infusion chemotherapy alone; HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; AFP: α-fetoprotein; ALBI: Ascites and albumin-bilirubin.